MedTrace Logo

Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7%

NCT02414581 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-05-25

No results posted yet for this study

Summary

Clinical triple-blind randomized controlled trial to assess the use of two different mouthwashes to reduce the oral colonization by gramnegative bacteria in patients with chemotherapy

Conditions

Interventions

DRUG

chlorhexidine 0.12%/Ethyl alcohol 7%

Mouth rinses with chlorhexidine 0.12%-based solution

DRUG

Ethyl Alcohol 7%

Mouth rinses with Ethyl Alcohol 7%-based solution

DRUG

Chlorhexidine 2%/Ethyl alcohol 7%

Mouth rinses with chlorhexidine 2%-based solution

Sponsors & Collaborators

  • Universidad de Guanajuato

    collaborator OTHER

  • Hospital Regional de Alta Especialidad del Bajio

    lead OTHER

Principal Investigators

  • Lauro F Amador, Researcher · Hospital Regional Alta Especialidad Bajio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-08-31
Completion
2016-09-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02414581 on ClinicalTrials.gov